Hyperparathyroidism: High Calcium, Bone Loss, and Treatment Options

Hyperparathyroidism occurs when the parathyroid glands produce too much parathyroid hormone, which can disturb calcium balance and affect bones, kidneys, muscles, and overall well-being. Many people are diagnosed through routine blood tests, and treatment may range from monitoring and medication to minimally invasive surgery.

Overview

Hyperparathyroidism is a hormone condition in which one or more of the parathyroid glands produce too much parathyroid hormone, often called PTH. The parathyroid glands are four small glands in the neck, usually located behind the thyroid gland. Their main job is to help keep calcium and phosphorus levels in a healthy range.

When PTH is too high, calcium may be released from bones, absorbed more from the digestive tract, or retained by the kidneys. Over time, this can lead to high calcium levels in the blood, bone loss, and kidney-related problems such as kidney stones. Some people feel well and learn they have the condition only after routine blood tests show high calcium.

There are different types of hyperparathyroidism. Primary hyperparathyroidism starts in the parathyroid glands themselves, most often because one gland becomes overactive. Secondary hyperparathyroidism develops as a response to another problem, such as chronic kidney disease or vitamin D deficiency. Tertiary hyperparathyroidism can occur after long-standing secondary hyperparathyroidism, when the glands remain overactive.

Symptoms and Possible Complications

The symptoms of hyperparathyroidism can be mild, vague, or absent, especially in early disease. When symptoms occur, they may include tiredness, low energy, muscle weakness, increased thirst, frequent urination, constipation, nausea, abdominal discomfort, joint or bone pain, difficulty concentrating, sleep disturbance, low mood, or irritability. These symptoms can overlap with many other conditions, so medical evaluation is important.

High calcium levels can affect several body systems. The kidneys may work harder to filter calcium, which can increase the risk of kidney stones or, in some people, reduced kidney function. The bones may lose calcium gradually, increasing the risk of osteopenia, osteoporosis, and fractures. Some people also develop high blood pressure or nonspecific heart and blood vessel concerns, although the relationship can vary from person to person.

Complications are not inevitable. Many people are diagnosed before serious problems develop, and follow-up can help identify changes early. The goal of care is to protect bones and kidneys, control calcium levels, and address the underlying reason for excess PTH.

Causes and Risk Factors

Primary hyperparathyroidism is commonly caused by a benign growth in one parathyroid gland, called a parathyroid adenoma. Less often, more than one gland becomes enlarged, a situation known as hyperplasia. Parathyroid cancer is a rare cause and is not the usual explanation for high PTH or high calcium.

Secondary hyperparathyroidism occurs when the parathyroid glands are stimulated by low calcium signals over time. This is frequently seen in chronic kidney disease, because the kidneys help activate vitamin D and regulate phosphorus. Vitamin D deficiency, poor calcium absorption, certain digestive disorders, and some medications can also contribute.

Risk factors for primary hyperparathyroidism include increasing age, being female after menopause, a history of neck radiation, and certain inherited endocrine syndromes. Family history may matter in a small number of cases. Risk factors for secondary hyperparathyroidism include chronic kidney disease, limited vitamin D, malabsorption conditions, and long-term dietary or metabolic imbalances.

• Primary hyperparathyroidism: the gland is overactive and PTH is high despite normal or high calcium.
• Secondary hyperparathyroidism: PTH rises because the body is responding to low calcium, low vitamin D, kidney disease, or high phosphorus.
• Tertiary hyperparathyroidism: long-term gland stimulation leads to persistent overactivity, often in advanced kidney disease settings.

Diagnosis

Diagnosis usually begins with blood tests. Doctors typically check total calcium, sometimes ionized calcium, PTH, vitamin D, phosphorus, kidney function, and albumin, which helps interpret calcium results. In primary hyperparathyroidism, calcium is often high and PTH is inappropriately high or not suppressed. In secondary hyperparathyroidism, calcium may be low or normal, while PTH is elevated because the body is trying to correct another imbalance.

Urine testing is often useful. A 24-hour urine calcium test can help assess how much calcium is being lost in the urine and can help distinguish primary hyperparathyroidism from other inherited calcium conditions. It also provides information about kidney stone risk. Doctors may also request bone density testing with a DEXA scan to look for osteopenia or osteoporosis.

Imaging tests, such as neck ultrasound, sestamibi scan, 4D CT, or MRI, may be used if surgery is being planned. These tests help locate an overactive gland, but they do not confirm the diagnosis by themselves. The diagnosis is made mainly from laboratory results and clinical evaluation; imaging supports treatment planning.

Treatment Options

Treatment depends on the type of hyperparathyroidism, calcium level, symptoms, age, bone health, kidney health, and personal medical history. For primary hyperparathyroidism, surgery to remove the overactive parathyroid gland or glands is the only definitive treatment. Many operations can be performed through a focused or minimally invasive approach when imaging clearly identifies the abnormal gland.

Surgery is generally recommended for people with symptoms, kidney stones, reduced kidney function, osteoporosis, fragility fractures, or clearly elevated calcium. It may also be advised for younger patients or for those in whom careful monitoring is not a good option. During surgery, some centers measure PTH levels before and after gland removal to confirm that the source of excess hormone has been treated.

Some people with mild primary hyperparathyroidism who do not meet surgical criteria may be monitored with regular blood tests, kidney evaluation, and bone density scans. Medication may be considered when surgery is not suitable or is delayed. Options can include medicines that lower calcium levels, such as calcimimetics, and bone-protective medicines such as bisphosphonates or other osteoporosis therapies when appropriate.

Secondary hyperparathyroidism is treated by addressing the underlying cause. This may involve correcting vitamin D deficiency, managing phosphorus levels, optimizing calcium intake under medical guidance, and treating chronic kidney disease. People with kidney disease may require specialized therapies guided by a nephrologist and endocrinologist.

Prevention and Self-Care

Not all forms of hyperparathyroidism can be prevented, particularly primary hyperparathyroidism caused by an overactive gland. However, self-care can support bone and kidney health and may reduce the risk of complications. People should follow their doctor’s advice about calcium and vitamin D rather than starting or stopping supplements on their own, because needs vary depending on blood tests, kidney function, and the type of hyperparathyroidism.

Hydration is often important, especially for people with high calcium or kidney stone risk. Regular physical activity, including weight-bearing and strength exercises when safe, supports bone health. Avoiding smoking and limiting excessive alcohol can also help protect bones. People with osteoporosis risk may need fall-prevention strategies and medication review.

Follow-up is a key part of care. Monitoring may include calcium and PTH levels, kidney function tests, vitamin D levels, urine calcium, imaging for kidney stones, and repeat bone density scans. A structured plan helps doctors see whether the condition is stable or whether treatment should be adjusted.

When to See a Doctor

A person should seek medical evaluation if blood tests show high calcium, high PTH, unexplained bone loss, recurrent kidney stones, or persistent symptoms such as fatigue, muscle weakness, constipation, excessive thirst, frequent urination, or bone pain. These symptoms do not always mean hyperparathyroidism is present, but they deserve careful assessment.

People already diagnosed with hyperparathyroidism should contact their doctor if symptoms worsen, kidney stones occur, fractures happen, or calcium levels rise on follow-up testing. Prompt review is also important before taking calcium, vitamin D, or osteoporosis medications, because treatment should match the person’s laboratory results and kidney function.

International patients seeking evaluation may benefit from coordinated endocrinology, nephrology, radiology, and endocrine surgery care. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat hyperparathyroidism for international patients, with treatment planning based on individual test results and medical needs.

Frequently asked questions

Is hyperparathyroidism the same as a thyroid problem?

No. The parathyroid glands are located near the thyroid gland, but they have a different job. The thyroid controls metabolism through thyroid hormones, while the parathyroid glands regulate calcium and phosphorus through parathyroid hormone.

Can hyperparathyroidism cause osteoporosis?

Yes, especially primary hyperparathyroidism that remains untreated over time. Excess PTH can pull calcium from bones, leading to reduced bone density and a higher fracture risk. Bone density testing helps doctors assess this risk and decide on treatment.

Does everyone with hyperparathyroidism need surgery?

Not everyone needs surgery immediately. Surgery is often recommended when there are symptoms, high calcium, kidney stones, reduced kidney function, osteoporosis, or other risk factors. Some people with mild, stable disease may be monitored closely.

Can vitamin D help hyperparathyroidism?

Vitamin D can be important, particularly when deficiency is contributing to secondary hyperparathyroidism. In primary hyperparathyroidism, vitamin D may still need correction, but it should be done under medical supervision with calcium monitoring. A doctor can recommend the safest approach.

What tests confirm hyperparathyroidism?

Diagnosis is usually confirmed with blood tests showing an abnormal relationship between calcium and PTH. Doctors may also check vitamin D, phosphorus, kidney function, and urine calcium. Imaging tests are used mainly to locate an overactive gland before surgery.

What happens after parathyroid surgery?

After successful surgery for primary hyperparathyroidism, calcium and PTH levels often improve. Doctors monitor calcium levels after the operation, because some people need temporary calcium or vitamin D support while the bones and remaining glands adjust. Follow-up bone and kidney checks may still be recommended.

References

• Endocrine Society
• American Association of Endocrine Surgeons
• National Institute of Diabetes and Digestive and Kidney Diseases
• Mayo Clinic
• Kidney Disease: Improving Global Outcomes

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.